Document Detail


Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study.
MedLine Citation:
PMID:  19357525     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
OBJECTIVE: Our earlier study has demonstrated that the administration of L-acetylcarnitine (LAC) improves neurological symptoms and serum parameters in hepatic coma. The aim of this work has been to evaluate the efficacy of the LAC and branched chain amino acids (BCAA) versus BCAA, administered in intravenous infusion, in patients with cirrhotic hepatic coma. METHODS: Forty-eight highly selected patients were enrolled in the study and, after randomization, received blindly LAC+BCAA (n=24) versus BCAA (n=24). The two groups were similar in age, sex, pathogenesis of cirrhosis, and severity of liver disease. The comparison between values before and after LAC planned treatment showed statistical significant differences in neurological findings, evaluated by the Glasgow Scale, ammonia serum levels, blood urea nitrogen, and EEG. RESULTS: After 60 min of the study period, the LAC+BCAA treated patients compared with BCCA treated showed a significant decrease of ammonia serum levels: 41.20 versus 10.40 mumol P<0.05. After 1 day of the study period, the LAC+BCAA treated patients compared with BCCA treated patients showed a significant increase of Glasgow's score: 3.60 versus 1.50 score P<0.05; a significant decrease of ammonia serum levels: 63.30 versus 27.00 mumol P<0.01; a significant improvement of EEG cps/s: 2.70 versus 0.6 P<0.001. No side-effects were observed in our study series. CONCLUSION: Our study demonstrated that the administration of BCAA supplemented with LAC might improve neurological symptoms and serum ammonium levels in selected cirrhotic patients with hepatic coma.
Authors:
Mariano Malaguarnera; Corrado Risino; Lisa Cammalleri; Lucia Malaguarnera; Marinella Astuto; Ignazio Vecchio; Liborio Rampello
Related Documents :
20517675 - Fetuin-a as a risk factor for mortality in hemodialysis patients.
2720985 - Lactate dehydrogenase isoenzyme patterns in serum of patients with metastatic liver dis...
6464805 - Ceruloplasmin in human malignancies.
6137275 - Gamma-glutamyltranspeptidase levels as an aid in the management of human cancer.
8995745 - Proximal tubular injury in chinese herbs nephropathy: monitoring by neutral endopeptida...
21541455 - Leptospirosis-associated acute kidney injury.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of gastroenterology & hepatology     Volume:  21     ISSN:  1473-5687     ISO Abbreviation:  Eur J Gastroenterol Hepatol     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-06-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9000874     Medline TA:  Eur J Gastroenterol Hepatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  762-70     Citation Subset:  IM    
Affiliation:
Department of Senescence, Urological and Neurological Sciences, University of Catania, Italy. malaguar@unict.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cerebral gas embolism due to upper gastrointestinal endoscopy.
Next Document:  Lamotrigine-induced aseptic meningitis: a case report.